Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul J Rowan

Showing results (11-20 of 29) with videos related to

Pageof 3
Sort By:
Journal of Child and Adolescent Psychopharmacology|April 14, 2025
Does Concomitant Psychostimulants Mitigate Second-Generation Antipsychotics-Associated Weight Gain? An Observational Study Based on Electronic Medical Records DataNing Lyu, Paul J Rowan, Tyler J Varisco, et al.
Journal of Affective Disorders|April 30, 2019
The association between geographic access to providers and the treatment quality of pediatric depressionNavneet Upadhyay, Rajender Aparasu, Paul J Rowan, et al.
Journal of Child and Adolescent Psychopharmacology|February 26, 2024
Trajectories and Predictors for the Development of Clinically Significant Weight Gain in Children and Adolescents Prescribed Second-Generation AntipsychoticsNing Lyu, Paul J Rowan, Susan Abughosh, et al.
Journal of Clinical Psychopharmacology|January 23, 2024
Group-Based Trajectory Modeling to Identify Patterns of Antipsychotic-Associated Weight Gain Among Children and AdolescentsNing Lyu, Susan Abughosh, Tyler J Varisco, et al.
Journal of Psychiatric Research|October 5, 2025
Prediction of antipsychotic associated weight gain in children and adolescents taking second generation antipsychotics: A machine learning approachNing Lyu, Ying Lin, Paul J Rowan, et al.
Journal of Clinical Gastroenterology|June 29, 2004
Psychosocial factors are the most common contraindications for antiviral therapy at initial evaluation in veterans with chronic hepatitis CPaul J Rowan, Shahriar Tabasi, Mariam Abdul-Latif, et al.
Journal of Law and the Biosciences|June 6, 2018
Constraints on gene patent protection fuel secrecy concerns: a qualitative studyChristi J Guerrini, Amy L McGuire, Mary A Majumder, et al.
Journal of Psychiatric Research|July 28, 2023
Impact of the AACAP practice parameters on the metabolic adverse event monitoring for second-generation antipsychotics (SGAs) in children and adolescentsSwarnava Sanyal, Chadi A Calarge, Paul J Rowan, et al.
Journal of Child and Adolescent Psychopharmacology|August 23, 2024
Metabolic Monitoring for Children and Adolescents Prescribed Second-Generation Antipsychotics: A Qualitative Study with Child PsychiatristsSwarnava Sanyal, Paul J Rowan, Melissa Ochoa-Perez, et al.
Journal of Child and Adolescent Psychopharmacology|September 7, 2023
Association Between Abnormal Metabolic Parameters and Receiving Subsequent Interventions in Children and Adolescents Initiating Second-Generation AntipsychoticsSwarnava Sanyal, Ning Lyu, Chadi Calarge, et al.
Pageof 3

Showing results (11-20 of 29) with videos related to

Sort By:
Pageof 3
Journal of Child and Adolescent Psychopharmacology|April 14, 2025
Does Concomitant Psychostimulants Mitigate Second-Generation Antipsychotics-Associated Weight Gain? An Observational Study Based on Electronic Medical Records DataNing Lyu, Paul J Rowan, Tyler J Varisco, et al.
Journal of Affective Disorders|April 30, 2019
The association between geographic access to providers and the treatment quality of pediatric depressionNavneet Upadhyay, Rajender Aparasu, Paul J Rowan, et al.
Journal of Child and Adolescent Psychopharmacology|February 26, 2024
Trajectories and Predictors for the Development of Clinically Significant Weight Gain in Children and Adolescents Prescribed Second-Generation AntipsychoticsNing Lyu, Paul J Rowan, Susan Abughosh, et al.
Journal of Clinical Psychopharmacology|January 23, 2024
Group-Based Trajectory Modeling to Identify Patterns of Antipsychotic-Associated Weight Gain Among Children and AdolescentsNing Lyu, Susan Abughosh, Tyler J Varisco, et al.
Journal of Psychiatric Research|October 5, 2025
Prediction of antipsychotic associated weight gain in children and adolescents taking second generation antipsychotics: A machine learning approachNing Lyu, Ying Lin, Paul J Rowan, et al.
Journal of Clinical Gastroenterology|June 29, 2004
Psychosocial factors are the most common contraindications for antiviral therapy at initial evaluation in veterans with chronic hepatitis CPaul J Rowan, Shahriar Tabasi, Mariam Abdul-Latif, et al.
Journal of Law and the Biosciences|June 6, 2018
Constraints on gene patent protection fuel secrecy concerns: a qualitative studyChristi J Guerrini, Amy L McGuire, Mary A Majumder, et al.
Journal of Psychiatric Research|July 28, 2023
Impact of the AACAP practice parameters on the metabolic adverse event monitoring for second-generation antipsychotics (SGAs) in children and adolescentsSwarnava Sanyal, Chadi A Calarge, Paul J Rowan, et al.
Journal of Child and Adolescent Psychopharmacology|August 23, 2024
Metabolic Monitoring for Children and Adolescents Prescribed Second-Generation Antipsychotics: A Qualitative Study with Child PsychiatristsSwarnava Sanyal, Paul J Rowan, Melissa Ochoa-Perez, et al.
Journal of Child and Adolescent Psychopharmacology|September 7, 2023
Association Between Abnormal Metabolic Parameters and Receiving Subsequent Interventions in Children and Adolescents Initiating Second-Generation AntipsychoticsSwarnava Sanyal, Ning Lyu, Chadi Calarge, et al.
Pageof 3